🔎 Trials Near Me

Domov › Rak pljuč › Wisconsin › Madison

Klinične študije za Rak pljuč v Madison, WI

10 študij za Rak pljuč išče udeležence na lokacijah v Madison in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Vključevanje udeležencevFaza 1/2
  • University of Wisconsin Carbone Cancer Center, Madison
Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • Wisconsin Institute for Medical Research, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06625775

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05624996

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2
  • University of Wisconsin- Madison, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05592626

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2/3
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Vključevanje udeležencevFaza 2
  • University of Wisconsin, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 8. apr. 2026 · NCT04919382

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Vključevanje udeležencevFaza 2
  • University of Wisconsin, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 27. jun. 2025 · NCT03175224

Študije za Rak pljuč v drugih mestih

Druge študije v Madison

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.